• 1. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 4. Achieving crystal-induced room temperature phosphorescence and reversible photochromic properties by strong intermolecular interactions?
  Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
• 5. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinoline carboxylic acids

Recent Advances in the Study of 7-Methylquinoline-2-carboxylic acid (CAS: 75434-10-5)

7-Methylquinoline-2-carboxylic acid (CAS: 75434-10-5) is a quinoline derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have explored its role as a key intermediate in the synthesis of bioactive compounds, as well as its direct pharmacological properties. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic utility, biological activities, and potential therapeutic applications.

One of the most notable advancements in the study of 7-Methylquinoline-2-carboxylic acid is its use as a building block in the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory activity against several tyrosine kinases, which are implicated in various cancers. The researchers utilized a structure-activity relationship (SAR) approach to optimize the compound's efficacy, leading to the identification of derivatives with improved selectivity and reduced off-target effects.

In addition to its role in kinase inhibition, 7-Methylquinoline-2-carboxylic acid has been investigated for its antimicrobial properties. A recent study in Bioorganic & Medicinal Chemistry Letters reported that this compound and its analogs display broad-spectrum activity against both Gram-positive and Gram-negative bacteria. The study also highlighted the compound's ability to disrupt bacterial biofilm formation, suggesting its potential as a novel anti-infective agent. Further mechanistic studies revealed that the compound interferes with bacterial cell wall synthesis, a finding that could pave the way for the development of new antibiotics.

The compound's versatility extends to its application in fluorescence-based assays. Researchers have exploited the intrinsic fluorescence properties of 7-Methylquinoline-2-carboxylic acid to develop sensitive probes for detecting metal ions and small molecules in biological systems. A 2022 study in Analytical Chemistry described the use of this compound as a fluorescent tag for real-time monitoring of enzymatic reactions, offering a valuable tool for high-throughput screening in drug discovery.

Despite these promising developments, challenges remain in the optimization of 7-Methylquinoline-2-carboxylic acid for clinical use. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further preclinical studies. However, the compound's unique chemical scaffold and diverse biological activities make it a compelling candidate for continued research. Future directions may include the exploration of its role in neurodegenerative diseases and inflammatory conditions, as preliminary data suggest its potential to modulate key pathways involved in these disorders.

In conclusion, 7-Methylquinoline-2-carboxylic acid (CAS: 75434-10-5) represents a versatile and promising compound in the field of chemical biology and medicinal chemistry. Its applications span from drug discovery to diagnostic tools, underscoring its importance in advancing both basic and translational research. As new studies emerge, this compound is likely to remain a focal point for innovation in the development of novel therapeutics and biomedical technologies.

• 26469-60-3(Quinolinecarboxylic acid)
• 40609-76-5(4-Methylquinoline-2-carboxylic acid)
• 18474-59-4(6-Methyl-1H-indole-2-carboxylic acid)
• 103856-59-3(2-Quinolinecarboxylicacid, 5-methyl-)
• 93-10-7(Quinoline-2-carboxylic acid)
• 18474-57-2(4-Methyl-1H-indole-2-carboxylic acid)
• 10241-97-1(5-Methylindole-2-carboxylic acid)
• 5323-57-9(Quinoline-2,4-dicarboxylic Acid)
• 155602-27-0(2,5-Quinolinedicarboxylicacid)
• 383132-27-2(4,6-Dimethyl-1H-indole-2-carboxylic acid)